Atıf Formatları
Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. Eralp Et Al. , "Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model," BREAST CANCER RESEARCH , vol.6, no.4, 2004

Eralp, Y. Et Al. 2004. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model. BREAST CANCER RESEARCH , vol.6, no.4 .

Eralp, Y., Wang, X., Wang, J., Maughan, M., Polo, J., & Lachman, L., (2004). Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model. BREAST CANCER RESEARCH , vol.6, no.4.

Eralp, YEŞİM Et Al. "Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model," BREAST CANCER RESEARCH , vol.6, no.4, 2004

Eralp, YEŞİM Et Al. "Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model." BREAST CANCER RESEARCH , vol.6, no.4, 2004

Eralp, Y. Et Al. (2004) . "Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model." BREAST CANCER RESEARCH , vol.6, no.4.

@article{article, author={YEŞİM ERALP Et Al. }, title={Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model}, journal={BREAST CANCER RESEARCH}, year=2004}